aberrations and in shape sufficient to tolerate FCR therapy, should still be good candidates for your latter, With all the gain becoming this cure is often completed in 6 months even though ibrutinib must be taken indefinitely. Are BTK and PLCG2 mutations required and enough for ibrutinib resista